Pharma Market Access Insights - from Petauri Evidence

64 Afleveringen

1. Market access in the German speaking markets

   Gepubliceerd: 29-8-2023
2. The role of nursing in driving digital change in the NHS

   Gepubliceerd: 26-7-2023
3. Market access for digital therapies and digital medicines

   Gepubliceerd: 19-7-2023
4. A global market access journey in cannabinoid pharmaceuticals

   Gepubliceerd: 17-6-2023
5. Primary Care and ICBs – what is the next step in the integration journey?

   Gepubliceerd: 15-5-2023
6. Data-led transformation in the NHS - partnering to optimise patient care

   Gepubliceerd: 31-3-2023
7. Innovating for better health – research, collaboration and innovation in the NHS

   Gepubliceerd: 7-3-2023
8. Healthcare, economics and society – unlocking NHS collaboration

   Gepubliceerd: 30-1-2023
9. Specialised Commissioning in the NHS – What do you need to know now

   Gepubliceerd: 13-1-2023
10. Why are we waiting? - Pressures facing the NHS and how to deliver change

    Gepubliceerd: 29-11-2022
11. Priority setting in primary care - NHS insights

    Gepubliceerd: 18-10-2022
12. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    Gepubliceerd: 9-8-2022
13. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    Gepubliceerd: 1-8-2022
14. Transforming systems and care pathways for an integrated NHS

    Gepubliceerd: 21-6-2022
15. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    Gepubliceerd: 4-5-2022
16. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    Gepubliceerd: 15-3-2022
17. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    Gepubliceerd: 11-2-2022
18. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    Gepubliceerd: 17-1-2022
19. Optimising the NHS – How will medicines be valued in integrated systems?

    Gepubliceerd: 21-12-2021
20. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    Gepubliceerd: 29-11-2021